Trial Profile
Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary) ; Oxazepam (Primary) ; Metamfetamine
- Indications Drug dependence
- Focus Pharmacodynamics
- 13 Sep 2018 Status changed from active, no longer recruiting to completed.
- 09 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Apr 2017 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.